Anantharaman Vathsala

LIPID ABNORMALITIES IN CYCLOSPORINE-PREDNISONE-TREATED RENAL TRANSPLANT RECIPIENTS

Anantharaman Vathsala, Richard B. Weinberg, Linda Schoenberg et al. · Transplantation · 1989 · 207 citations

Medicine, Nephrology, Pharmacotherapy +16

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Health-related quality of life of Asian patients with end-stage renal disease (ESRD) in Singapore

Fan Yang, Konstadina Griva, Anantharaman Vathsala et al. · Quality of Life Research · 2015 · 115 citations

Medicine, Internal Medicine, Nephrology +11

Randomized Trial of Alemtuzumab for Prevention of Graft Rejection and Preservation of Renal Function after Kidney Transplantation1

Anantharaman Vathsala, E.T. Ona, S P Tan et al. · Transplantation · 2005 · 109 citations

Life Sciences, Immunology, Pharmacology +17

Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Vivekanand Jha, Allan J. Collins, Guillermo García-García et al. · Kidney International · 2016 · 107 citations · Full text

Medicine, Health Policy, Nephrology +17